RAD51C and neoplasm: To further investigate the potential pathogenicity of candidate variants, we exploited the fact that RAD51C appears to conform to Knudson’s “two-hit” hypothesis, and performed tumour sequencing from variant carriers to assess for biallelic inactivation and associated homologous recombination deficiency (HRD).